Advancing Behavioral Interventions Throughout the Life Course

项目摘要/摘要 这项R13会议拨款将通过为尖端技术提供论坛来推动行为医学领域的发展 与进行机制驱动的行为干预相关的研究，并通过支持不同的 一组有前途的早期调查人员(Esis)。行为医学学会的使命 举办这次会议的组织研究(ABMR)是为了推动行为医学领域的发展 通过创造和传播知识，培养话语，激励变革，最终实现更好的 人人健康。ABMR的成员是杰出的医学博士和博士科学家，由同行选举产生 对行为医学有突出贡献。这项会议拨款将使ABMR能够邀请领导人 来自不同领域的专家，以加强跨学科的思想交流。2023年年会将是 围绕“在整个生命过程中推进行为干预”这一主题进行了组织。这个 潜在的前提是行为医学领域缺乏一种系统的方法来发展 干预措施。因此，很少有成功的行为干预措施被整合到实践中。目标是 这次会议的重点将是将实验医学方法应用于 干预性发展。通过这种方式，会议方案将传播由 美国国立卫生研究院的行为改变科学倡议。会议将于2023年6月8日至11日在 位于艾伯塔省班夫的班夫艺术创意中心。这笔R13赠款将支持3位主讲人的参与 整合与确定行为干预的优先顺序和创新行为试验相关问题的演讲者 方法(目标1)。该计划还将包括围绕数字等主题组织的5个研讨会 健康创新、针对心脏代谢健康不平等的干预措施和实施科学。 该计划还将有4个圆桌讨论，以解决紧迫的问题，如如何最好地 优先安排下一次大规模的行为试验。NIH项目官员将被整合到会议活动中。 将讨论贯穿整个生命周期的干预措施。与美国国立卫生研究院的下一代倡议相一致 旨在培养成功的下一代行为医学研究人员。与此一致 目标，这笔R13赠款还将为2021年建立的ABMR早期调查员(ESI)计划提供资金，以及 现在每年交付给有潜力成为未来领导者的Esis。我们会特别注意 招募包括代表人数不足的少数群体在内的不同的ESI群体(目标2)。除了提供 参会资金为10个ESI，此奖项将支持ESI会议前半天的领导力 培训、职业发展研讨会，以及通过导师计划与ABMR科学家进行1：1网络交流 (目标3)。总而言之，R13将传播创新的方法，通过领导者在 并将推动下一代多元化行为医学研究人员的成功。

Project Summary/Abstract This R13 conference grant will advance the field of behavioral medicine by providing a forum for cutting edge research relevant to the conduct of mechanism-driven behavioral interventions and by supporting a diverse group of promising early-stage investigators (ESIs). The mission of the Academy of Behavioral Medicine Research (ABMR), the organization conducting this conference, is to advance the field of behavioral medicine by creating and disseminating knowledge, cultivating discourse, and inspiring change that culminates in better health for all. The members of ABMR are distinguished MD and PhD scientists, elected by peers for outstanding contributions to behavioral medicine. This conference grant will enable ABMR to invite leaders from diverse fields to enhance the exchange of ideas across disciplines. The 2023 annual meeting will be organized around the theme “Advancing Behavioral Interventions Throughout the Life Course”. The underlying premise is that the field of behavioral medicine has lacked a systematic approach to developing interventions. As a result, few successful behavioral interventions have been integrated into practice. The goal of this conference will be to spotlight research that applies the experimental medicine approach to intervention development. In this manner, the conference program will disseminate the methods promoted by the NIH’s Science of Behavior Change initiative. The meeting will take place from June 8-11, 2023 at the Banff Centre for Arts and Creativity in Banff, Alberta. This R13 grant will support the participation of 3 keynote speakers who integrate issues relevant to prioritizing behavioral interventions and innovating behavioral trial methodologies (Aim 1). The program will also include 5 symposia organized around themes such as digital health innovations, interventions targeting inequities in cardiometabolic health, and implementation science. The program will also feature 4 roundtable discussions that tackle pressing issues such as how best to prioritize the next big behavioral trial. NIH program officials will be integrated into conference activities. Interventions across the lifespan will be discussed. Consistent with the NIH’s Next Generation Initiative, ABMR aims to nurture the success of the next generation of behavioral medicine researchers. Consistent with this goal, this R13 grant will also fund the ABMR Early-Stage Investigator (ESI) Program, established in 2021, and now delivered annually to promising ESIs with potential to become future leaders. Special attention will be paid to recruiting a diverse group of ESIs inclusive of under-represented minorities (Aim 2). In addition to providing funds for 10 ESIs to attend the meeting, this award will support a half-day pre-conference ESI leadership training, a career development workshop, and 1:1 networking with ABMR scientists via a mentorship program (Aim 3). In summary, this R13 will diffuse innovative approaches to conducting behavioral trials via leaders in the field and will promote the success of the next generation of diverse behavioral medicine researchers.